Legal Representation
Attorney
Chelsea E. Carbone
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 25, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 25, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 20, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 19, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jan 17, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jan 17, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 3, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 3, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 3, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 3, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 3, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Feb 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 1, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 1, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 10, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 6, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 4, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 4, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 4, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 30, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 28, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 28, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 28, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 25, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 30, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 30, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 10, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 27, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2020 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Apr 3, 2020 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 28, 2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 7, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 6, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 6, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 3, 2020 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Oct 8, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 8, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 8, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 13, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 12, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 12, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 20, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 20, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 20, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 23, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 3, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, geriatric, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal system, diseases of aging, diseases of the blood, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, psychiatric diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, hereditary, and physiological diseases
Additional Information
Translation
The English translation of "EMPIRICO" in the mark is "EMPIRICAL".
Classification
International Classes
005